Sangamo Therapeutics, Inc
SGMOQ· OTC
Sangamo Therapeutics, Inc
- Close
- Sep 11, 2026
- Market cap
- $62.14M
- 414.29M shares
- Filings
- 1,015
Price
Sep 11, 2026 · Official close
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $39,552,000 | reported | |
| FY 2024 | 2024-12-31 | $57,800,000 | reported | |
| FY 2023 | 2023-12-31 | $176,232,000 | reported | |
| FY 2022 | 2022-12-31 | $111,299,000 | reported | |
| FY 2021 | 2021-12-31 | $110,701,000 | reported | |
| FY 2020 | 2020-12-31 | $118,192,000 | reported | |
| FY 2019 | 2019-12-31 | $102,428,000 | reported | |
| FY 2018 | 2018-12-31 | $84,452,000 | reported | |
| FY 2017 | 2017-12-31 | $36,567,000 | reported | |
| FY 2016 | 2016-12-31 | $19,389,000 | reported | |
| FY 2015 | 2015-12-31 | $39,539,000 | reported | |
| FY 2014 | 2014-12-31 | $45,870,000 | reported |
Sangamo Therapeutics, Inc · CIK 1001233 · Engraved from SEC EDGAR
